MedPath

The effectiveness of vitamin D supplementation on schizophrenia symptoms

Not Applicable
Recruiting
Conditions
Schizophrenia.
Schizophrenia
Registration Number
IRCT20231109060002N1
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
72
Inclusion Criteria

Diagnosis of chronic outpatient schizophrenia (at least three years have passed since the onset of the disease and at least one year under treatment with antipsychotic drugs) based on DSM5 by a psychiatrist
Vitamin D level below 30ng
under treatment for at least 8 weeks with a fixed dose of the drug
score question (PANSS) above 70

Exclusion Criteria

Received ECT in the past two months
Mental retardation
Organic brain disease and history of head trauma
History of drug and alcohol use
Non-cooperation in filling out the questionnaire
Non-cooperation in taking medicine or changing its dosage?
Non-cooperation in taking vitamin D supplements
Kidney, heart, thyroid disorders and diseases, hemorrhagic diseases and malignancies
Pregnancy and breastfeeding

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath